Showing results (151-160 of 183) with videos related to
Sort By:
Pageof 19
Anti-Cancer Drugs|October 20, 2012
Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124]Stephan Seitz, Stefan Buchholz, Andrew V Schally, et al.Cancer Cell International|March 28, 2025
Breast cancer scoring based on a multiplexed profiling of soluble and cell-associated (immune) markers facilitates the prediction of pembrolizumab therapyVerena Schweihofer, Christina Bruss, Stephan Seitz, et al.Journal of Cancer Research and Clinical Oncology|July 7, 2023
Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?Maria Eleni Hatzipanagiotou, Miriam Pigerl, Michael Gerken, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO studyBernd Gerber, Gunter von Minckwitz, Heinrich Stehle, et al.Journal of Cancer Research and Clinical Oncology|January 6, 2020
Long-term outcome of patients with intermediate- and high-risk endometrial cancer after pelvic and paraaortic lymph node dissection: a comparison of laparoscopic vs. open procedureThomas Papathemelis, Helen Oppermann, Stella Grafl, et al.Oncology Reports|July 30, 2009
Neoadjuvant chemotherapy with carboplatin and docetaxel in advanced ovarian cancer--a prospective multicenter phase II trial (PRIMOVAR)Martin Pölcher, Sven Mahner, Olaf Ortmann, et al.International Journal of Oncology|September 3, 2009
Triple-negative breast cancers express receptors for luteinizing hormone-releasing hormone (LHRH) and respond to LHRH antagonist cetrorelix with growth inhibitionStefan Buchholz, Stephan Seitz, Andrew V Schally, et al.BMC Cancer|November 21, 2014
Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125Stephan Seitz, Stefan Buchholz, Andrew Victor Schally, et al.Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 21, 2021
[Routine Practice Data for Evaluating Intervention Effects: Part 2 of the Manual]Falk Hoffmann, Thomas Kaiser, Christian Apfelbacher, et al.BMC Cancer|June 6, 2021
Use of social service counseling by cancer patients: an analysis of quality assurance data of 6339 breast cancer patients from 13 certified centers in Germany treated between 2015 and 2017Clara Breidenbach, Simone Wesselmann, Nora Tabea Sibert, et al.Pageof 19